Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation.

Seaton, A., Scullin, P., Maxwell, P. J., Wilson, C., Pettigrew, J., Gallagher, R., O'Sullivan, J. M., Johnston, P. G., Waugh, D. J. J.·2008·Carcinogenesis
DOI 10.1093/carcin/bgn109

Cited by (143)

Items 101–143 of 143

  1. A Prospective Clinical Study of the Implications of IL-8 in the Diagnosis, Aggressiveness and Prognosis of Prostate Cancer
    Thierry Roumeguère, F. Legrand, Elie Rassy, Mehdi Idrissi Kaitouni, Simone Albisinni, Alexandre Rousseau, Michel Vanhaeverbeek, Sandrine Rorive, Christine Decaestecker, Olivier Debeir et al. · 2017 · Future Science OA
  2. Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist–Treated Prostate Cancers
    Pamela J. Maxwell, Melanie McKechnie, Christopher W. Armstrong, Judith M. Manley, Chee Wee Ong, Jenny Worthington, Ian Geoffrey Mills, Daniel B. Longley, James P. Quigley, Amina Zoubeidi et al. · 2022 · Molecular Cancer Research
  3. CXCL8, an Underestimated “Bad Guy” in Prostate Cancer
    Zoran Čulig · 2012 · European Urology
  4. Activation of lymphotoxin-beta receptor enhances the LPS-induced expression of IL-8 through NF-κB and IRF-1
    Seok-Won Jang, Su‐Geun Lim, Kyoungho Suk, Won‐Ha Lee · 2015 · Immunology Letters
  5. MicroRNA-106a suppresses prostate cancer proliferation, migration and invasion by targeting tumor-derived IL-8
    Pengfei Shen, Guangxi Sun, Peng Zhao, Jindong Dai, Xingming Zhang, Jinge Zhao, Sha Zhu, Junru Chen, Ronggui Tao, Jiyu Yang et al. · 2020 · Translational Cancer Research
  6. Dura promotes metastatic potential in prostate cancer through the CXCR2 pathway
    Michael J. Strong, Sabrina Rocco, Russell S. Taichman, Gregory A. Clines, Nicholas J. Szerlip · 2021 · Journal of Neuro-Oncology
  7. Activity of Chemokines in Prostate and Renal Tumors and their Potential Role as Future Therapeutic Targets
    Alessia Cimadamore, Marina Scarpelli, Francesco Piva, Francesco Massari, Silvia Gasparrini, Andrea Doria, Liang Cheng C, Antonio Lopez-beltran B, Rodolfo Montironi · 2017 · Future Oncology
  8. Tumor Dormancy, Quiescence, and Senescence, Volume 1
    M. A. Hayat · 2013 · Springer eBooks
  9. Tumor Dormancy, Quiescence, and Senescence, Volume 2
    M. A. Hayat · 2013 · Springer eBooks
  10. Neutrophil-mediated alteration of CXCL1/IL-8/AR signaling promotes prostate cancer cell proliferation
    Zhifu Liu, Yuxuan Tian, Zheng Li, Zhen Li, Kehao Yang, Yiming Zeng, Jiao Hu, Yuanwei Li, Xiongbing Zu, Shuai Hu · 2025 · Experimental Cell Research
  11. IL-6 causes multiple effects in androgen-sensitive and -insensitive prostate cancer cell lines
    Zoran Čulig · 2011 · Expert Review of Endocrinology & Metabolism
  12. CXCR1 Expression in MDA-PCa-2b Cell Upregulates ITM2A to Inhibit Tumor Growth
    Timothy O. Adekoya, Nikia Smith, Parag Kothari, Monique A. Dacanay, Yahui Li, Ricardo Micheler Richardson · 2024 · Cancers
  13. Elimination of docetaxel-induced senescence attenuates malignant progression in RB1-deficient CRPC
    Huilan Su, Liqun Huang, Wenwen Xia, Dean G. Tang, Jianjun Zhou, Guosheng Yang · 2025 · Cellular Oncology
  14. Assessment of Serum Soluble Toll-like Receptor-4 and Interleukin-8 as Biomarkers in Patients with Breast Cancer
    Ikram Khazal Al-Hasso · 2024 · Al-Rafidain Journal of Medical Sciences
  15. The Biology of Aging and the Development of Lower Urinary Tract Dysfunction and Disease
    Jill A. Macoska, Sathish Kasina, Lysanne Campeau, Karl‐Erik Andersson · 2014 · Springer eBooks
  16. Inflammatory Microenvironment in Prostate Carcinogenesis
    Geraldine Gueron, Javier Cotignola, Elba Susana Vazquez · 2013 · InTech eBooks
  17. The Role of Androgen Receptor in Prostate Cancer
    Adeline Berger, David S. Rickman · 2017 · Molecular pathology library
  18. Prostat-Specific Antigen: Biochemical, Molecular-Biological, and Analytical Aspects
    Yana Sydyakina, Anastasia Sivakova, Anatolii Komar, Alexander Galkin · 2019 · Innovative Biosystems and Bioengineering
  19. Tumor Dormancy, Quiescence, and Senescence, Vol. 3
    Muhammad Azeem Hayat · 2014 · Springer eBooks
  20. Evaluation of Plasma Interleukin-8 Concentration in Patients with Prostate Cancer and Benign Prostate Hyperplasia
    Mehdi Dehghani, Zohreh Mostafavi‐Pour, Mehrzad Lotfi, Saeed Shakeri · 2009 · PubMed
  21. Roles of hepatitis B X-interacting protein in tumor development
    Xue Wang, Tianzhi Jin, L. Ye, W.Q. Zhang, Xueli Fu · 2019 · Scientia Sinica Vitae
  22. Adipose Tissue and Cancer
    Noor Bakour, Claudine Duggan, Stephanie Annett · 2025 · IntechOpen eBooks
  23. How the overexpressed hPTTG1 gene promotes metastasis in breast cancer
    Ji-Hshiung Chen · 2013 · Tzu Chi Medical Journal
  24. Pediatric Cancer, Volume 3
    Hayat, M. A · 2012 · Pediatric cancer
  25. Metformin alters signaling induced crosstalk and homeostasis in the carcinogenesis paradigm “Epistemology of the origin of cancer”
    Björn L.D.M. Brücher, Ijaz S. Jamall · 2019 · 4open
  26. Reply from Authors re: Zoran Culig. CXCL8, an Underestimated “Bad Guy” in Prostate Cancer. Eur Urol 2013;64:189–90
    David J J Waugh · 2012 · European Urology
  27. REDOX-REGULATED RELB-AR AXIS MEDIATES PROSTATE SPECIFIC ANTIGEN EXPRESSION: INSIGHT IN PROSTATE CANCER RESPONSE TO RADIATION THERAPY
    Miao Lu · 2013 · UKnowledge (University of Kentucky)
  28. Regulating Prostate Cancer Sensitivity to Chemotherapy through Translational Control of CCAAT Enhancer Binding Proteins
    David J. Barakat, Samuel Ray Denmeade, Alan D. Friedman · 2015 · Defense Technical Information Center (DTIC)
  29. The Role Of IL-8-Mediated Src Family Kinase Activation In Tumor-Tumor And Tumor-Stromal Interactions In Metastasis Of Prostate Cancer
    Lynnelle Thorpe · 2013 · Digital Commons-TMC (Texas Medical Center)
  30. TARGETING PROTEIN KINASE D BY NOVEL SMALL MOLECULE INHIBITORS AND RNA INTERFERENCE IN PROSTATE CANCER
    Courtney R. LaValle · 2011 · D-Scholarship@Pitt (University of Pittsburgh)
  31. Formation of Secretory Senescent Cells in Prostate Tumors: The Role of Androgen Receptor Activity and Cell Cycle Regulation
    Zuzana Pernicová, Petr Vaňhara, Karel Souček · 2013 · Springer eBooks
  32. Modeling and Analysis of Hormone and Mitogenic Signal Integration in Prostate Cancer
    Katharine V. Rogers, Joseph A. Wayman, Ryan A. Tasseff, Caitlin Gee, Matthew P. DeLisa, Jeffrey D. Varner · 2016 · bioRxiv (Cold Spring Harbor Laboratory)
  33. Tumors of the Central Nervous System, Volume 9
    Hayat, M. A · 2012 · Springer eBooks
  34. The role of cytokines in governing the expansion of the T315I mutation in chronic myeloid leukaemia.
    Oi-Lin Lee · 2014 · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
  35. Characterizing the Role of Insulin Signalling in Advanced Prostate Cancer
    Phoebe L. Sarkar · 2017 · Queensland University of Technology
  36. Reconnaissance of the candidate genes involved in the pathogenesis of human immunodeficiency virus and targeted by antiretroviral therapy
    Sayed‐Hamidreza Mozhgani, Mohadeseh Zarei Ghobadi, Mohammad Behnam Rad, Mahdieh Farzanehpour, Farida Behzadian · 2019 · Journal of Medical Virology
  37. High dose everolimus promotes a pro-inflammatory phenotype and facilitates the epithelial to mesenchymal transition of primary bronchial epithelial cells isolated from cystic fibrosis patients.
    Simona Granata, Gloria Santoro, Valentina Masola, Paola Pontrelli, Fabio Sallustio, Gianmarco Lombardi, Alberto Verlato, Gianluigi Zaza · 2020 · Research Square
  38. High-dose Everolimus May Induce Pro-inflammatory/Fibrotic Transcriptomic Changes in Bronchial Epithelial Cells from Cystic Fibrosis Patients
    Simona Granata, Alberto Verlato, Valentina Masola, Amedeo Carraro, Gloria Santoro, Fabio Sallustio, Gianluigi Zaza · 2021 · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine
  39. Androgen metabolism in castration-resistant prostate cancer
    Tomas Koltai, Stephan J. Reshkin, Fátima Baltazar, Larry Fliegel · 2021 · Elsevier eBooks
  40. Describing mechanisms supporting macrophage-promoted escape of PTEN-deficient prostate cancer cells to understand disease recurrence
    Suzanne McCusker · 2023 · Queensland University of Technology
  41. Regulação do promotor SMyHC3 pelos receptores nucleares GR e COUP-TFII
    Izabella Tambones · 2020
  42. Obesogens in Prostate Cancer: An Endocrine and Metabolic Threat
    Mariana Feijó, Lara R. S. Fonseca, Endre Kiss‐Toth, Sílvia Socorro, Sara Trindade Correia · 2026 · Current Obesity Reports
  43. Rôle des chimiokines dans les interactions entre les cellules stromales mésenchymateuses et les cellules de cancer du sein
    Pauline Arias Escobar · 2010 · theses.fr (ABES)